EUVIMEDEUVIMED entdecken
Crossref

Multi-Ion Channel Nanomedicines Targeting Zinc Transporter 1/ATPase Copper Transporters Disrupt Copper/Iron Homeostasis to Enhance Tumor Immunotherapy

Guangyu Ma, Yuting Li, Xiang Li, Dehong Yu, Minghao Chao, Jiale Li, Jintao Guo, Ke Wang, Zhao Liu, Rongrong Sun, Fenglei Gao iD

ACS Nano · 21.04.2026 · 20 (15) · 11801-11821

DOI: 10.1021/acsnano.6c00358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 07.04.2026. Verfasst von Guangyu Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xuzhou Central Hospital, 221004 Xuzhou, China. Hauptthemen laut MEDLINE: Copper, Iron, Immunotherapy, Nanomedicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Xuzhou Pengcheng Talent Program, Natural Science Foundation of Jiangsu Province, Jiangsu Province High level Hospital Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperIronImmunotherapyNanomedicineIon ChannelsCopper-Transporting ATPasesHomeostasisAnimalsHumansMiceFerroptosisCuproptosisCell Line, Tumor

Stichwörter der Autor:innen

cuproptosisferroptosisimmune activationion homeostasismulti-ion interference

Substanzen

CopperIronIon ChannelsCopper-Transporting ATPases

Autor:innen und Institutionen

  • Department of Oncology, Xuzhou Central Hospital, 221004 Xuzhou, China.
  • Key Laboratory of New Drug Research and Clinical Pharmacy of Jiangsu Province, Xuzhou Medical University, Jiangsu 221004, China.
  • Department of Clinical Laboratory, Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, China.
  • The Affiliated Pizhou Hospital of Xuzhou Medical University, Jiangsu 221399, China.
  • Department of Orthopaedic Surgery, Lishui Central Hospital and Fifth Afffliated Hospital of Wenzhou Medical University, Lishui 323000, Zhejiang, China.
  • Department of Thyroid and Breast Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.

ORCID-Profile: Fenglei Gao

Förderung

  • Xuzhou Pengcheng Talent Program
  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Province High level Hospital Construction Project

Zitieren

APA

Ma, G., Li, Y., Li, X., Yu, D., Chao, M., Li, J., Guo, J., Wang, K., Liu, Z., Sun, R., & Gao, F. (2026). Multi-Ion Channel Nanomedicines Targeting Zinc Transporter 1/ATPase Copper Transporters Disrupt Copper/Iron Homeostasis to Enhance Tumor Immunotherapy. ACS Nano, 20(15), 11801-11821. https://doi.org/10.1021/acsnano.6c00358

Vancouver

Ma G, Li Y, Li X, Yu D, Chao M, Li J, et al. Multi-Ion Channel Nanomedicines Targeting Zinc Transporter 1/ATPase Copper Transporters Disrupt Copper/Iron Homeostasis to Enhance Tumor Immunotherapy. ACS Nano. 2026;20(15):11801-11821. doi:10.1021/acsnano.6c00358

BibTeX
@article{Ma2026,
  author = {Ma, Guangyu and Li, Yuting and Li, Xiang and Yu, Dehong and Chao, Minghao and Li, Jiale and Guo, Jintao and Wang, Ke and Liu, Zhao and Sun, Rongrong and Gao, Fenglei},
  title = {Multi-Ion Channel Nanomedicines Targeting Zinc Transporter 1/ATPase Copper Transporters Disrupt Copper/Iron Homeostasis to Enhance Tumor Immunotherapy},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {15},
  pages = {11801--11821},
  doi = {10.1021/acsnano.6c00358}
}
Kostenlos starten →